Atlas Systems bags new deal from US based healthcare IT solutions provider

 

Princeton, NJ, January 19, 2015 -- Atlas Systems Inc. is pleased to announce that it has signed a deal with US based Technology Solutions company for their Electronic Health Record (EHR) solution upgrade.

Atlas System was chosen to upgrade the current client-server application to conform to current government regulations, within the deadline set by the regulatory authorities. The client has health integration framework that connects physicians and other healthcare professionals giving them secure access to data in a patient’s EHR and enabling health teams to have access to the accurate and up-to date information they need.

As part of the deal, Atlas’ highly qualified set of experts will perform the upgrade during the specified hours and meet the deadline related to the regulatory compliance and strengthen the availability, reliability of the application and keep it current. This strategic contract is an offshore engagement aiming to provide an optimal combination agility, flexibility and quality required by the client.

Atlas has established a strong footprint in the US and global space with the latest and most technically advanced tools to build a state-of-the art solution that fits the emerging Information technology needs of each industry. With this win, Atlas Systems continues to ensure we are able to offer our customers the efficiencies they need whilst allowing us to focus on the right blend of service innovation and creativity.

About Atlas: Atlas Systems Inc. is a leading technology innovator, offering software and service solutions to global and mid-market companies in a range of different industries, including BFSI, Healthcare& Finance, Insurance and Manufacturing. Atlas Systems proprietary products such as ComplyScore® and PRIME® provide a range of GRC and provider solutions. Our Learning, Technology and Oracle solutions provide future ready, tailor made services to enterprises across the globe. The goal is to deliver serious and competitively priced products and services to our clients that add business value that will have positive impact on their business.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.